HEMOCHROMATOSIS AND HEPATOCELLULAR CARCINOMA

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Aydın Sağlık Dergisi
Cilt: 11 Sayı: 1
HEMOCHROMATOSIS AND HEPATOCELLULAR CARCINOMA

HEMOCHROMATOSIS AND HEPATOCELLULAR CARCINOMA

Authors : Merve Çiğdem Özgel, Buğra Tuncer

Pages : 1-31

View : 23 | Download : 20

Publication Date : 2025-02-28

Article Type : Review Paper

Abstract :An autosomal recessive iron overload condition called hemochromatosis is typified by enhanced dietary iron sorption and hepatic iron buildup. It is a risk agent for hepatocellular carcinoma since it is a prevalent illness in the European population. One of the tumors that is most common and deadly around the globe, particularly in Asia, is hepatocellular carcinoma. Because it is often detected in its advanced stages, hepatocellular carcinoma has a weak prognosis. Early tumor detection improves the chances of a successful cure and a longer life. Because of this, the EASL (European Association for the Study of the Liver) instructions support liver tumor screening using ultrasound scanning every six months, regardless of liver condition. This review focuses on the relationship between hemochromatosis, a rare disorder that is among the risk factors, and hepatocellular carcinoma.
Keywords : Hemochromatosis, Hepatocellular carcinoma, HFE gene, Iron, Iron overload

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.